Cost-effective care is an increasingly important issue in medicine. Th
is will necessitate re-evaluating many aspects of antenatal and intrap
artum care, including health-care delivery systems and routine surveil
lance techniques for uncommon events such as Down syndrome. It will de
mand justification for broadening indications for cesarean section by
including fetal macrosomia and intensify the search for the causes of
preterm labor. As new techniques are developed for intrapartum monitor
ing, such as fetal electrocardiography, fetal lactic acid levels, and
near-infrared spectroscopy, they, too, will have to be determined to b
e cost-effective before attaining a role in clinical management.